UBS Assumes 10X Genomics (TXG) at Neutral

September 9, 2026 6:08 AM

UBS analyst Douglas Schenkel assumes coverage on 10X Genomics (NASDAQ: TXG) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found